MacroGenics Competitors and Similar CompaniesClear all
MacroGenics's competitors and similar companies include Livzon Pharmaceutical Group, Cadila Pharmaceuticals, Cipla and Biogen.
 MacroGenics MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2000 | Founding Date 1985 | Founding Date 1951 | Founding Date 1935 | Founding Date 1978 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Rockville, US HQ Brisbane, US Rockville, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees 3845% increase | Employees 9,067 | Employees 8,5201% increase | Employees 27,764 | Employees 7,605 |
Valuation ($) | Valuation ($) 209.5 m | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $149.5m (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods ₹97.2b (FY, 2026) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A | Gross profit ₹184.4b (FY, 2026) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($74.6m) (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company